皮膚肥満細胞症(Cutaneous Mastocytosis):治療薬開発パイプライン動向2019

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DIPR2016159)
◆英語タイトル:Cutaneous Mastocytosis-Pipeline Insights, 2019
◆発行会社/調査会社:DelveInsight
◆商品コード:DIPR2016159
◆発行日:2019年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:約60
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(受注後3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥142,500見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥285,000見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥456,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[皮膚肥満細胞症(Cutaneous Mastocytosis):治療薬開発パイプライン動向2019]についてメールでお問い合わせはこちら
※本調査レポートでは、世界における皮膚肥満細胞症(Cutaneous Mastocytosis)の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の薬剤リスト等をお届けしています。また、皮膚肥満細胞症(Cutaneous Mastocytosis)治療薬開発に取り組んでいる企業情報も提供しています。

・皮膚肥満細胞症(Cutaneous Mastocytosis)の概要

・皮膚肥満細胞症(Cutaneous Mastocytosis)の治療薬パイプライン概要

・企業別開発中の皮膚肥満細胞症(Cutaneous Mastocytosis)治療薬

・後期治験段階の薬剤(Filed & Phase III):比較分析

・中期治験段階の薬剤(Phase II):比較分析

・初期治験段階の薬剤(Phase I & IND Filed):比較分析

・前臨床段階の薬剤:比較分析

・薬剤候補のプロファイル

・皮膚肥満細胞症(Cutaneous Mastocytosis)治療薬の評価
  - 単剤治療薬別評価
  - 併用治療薬別評価
  - 投与経路別評価
  - 分子種類別評価

・開発が中止された薬剤リスト

・開発休止中の薬剤リスト

・皮膚肥満細胞症(Cutaneous Mastocytosis)治療薬開発に取り組んでいる企業リスト

・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s, “ Cutaneous Mastocytosis-Pipeline Insights, 2019”, report provides in depth insights on the pipeline drugs and their development activities around the Cutaneous Mastocytosis. The DelveInsight’sReport covers the product profiles in various stages of development including Discovery, Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration. Report covers the product clinical trials information and other development activities including technology, licensing, collaborations, acquisitions, fundings, patent and USFDA & EMA designations details. DelveInsight’s Report also provides detailed information on the discontinued and dormant drugs that have gone inactive over the years for Cutaneous Mastocytosis. DelveInsight’s Report also assesses the Cutaneous Mastocytosis therapeutics by Monotherapy, Combination products, Molecule type and Route of Administration.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated indication.


Scope
• The report provides competitivepipeline landscape of Cutaneous Mastocytosis
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Cutaneous Mastocytosis pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Cutaneous Mastocytosis and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


*** レポート目次(コンテンツ)***

Table of Contents
• Cutaneous Mastocytosis Overview
• Cutaneous Mastocytosis Pipeline Therapeutics
• Cutaneous Mastocytosis Therapeutics under Development by Companies
• Cutaneous Mastocytosis Filed and Phase III Products
• Comparative Analysis
• Cutaneous Mastocytosis Phase II Products
• Comparative Analysis
• Cutaneous Mastocytosis Phase I and IND Filed Products
• Comparative Analysis
• Cutaneous Mastocytosis Discovery and Pre-Clinical Stage Products
• Comparative Analysis
• Drug Candidate Profiles
• Cutaneous Mastocytosis – Therapeutics Assessment
• Assessment by Monotherapy Products
• Assessment by Combination Products
• Assessment by Route of Administration
• Assessment by Molecule Type
• Cutaneous Mastocytosis – Discontinued Products
• Cutaneous Mastocytosis – Dormant Products
• Companies Involved in Therapeutics Development for Cutaneous Mastocytosis
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Cutaneous Mastocytosis, 2019
• Number of Products under Development by Companies
• Comparative Analysis by Filed and Phase III Products, 2019
• Comparative Analysis Phase II Products, 2019
• Comparative Analysis Phase I and IND Filed Products, 2019
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2019
• Drug Candidates Profiles
• Cutaneous Mastocytosis Assessment by Monotherapy Products
• Cutaneous Mastocytosis Assessment by Combination Products
• Cutaneous Mastocytosis Assessment by Route of Administration
• Cutaneous Mastocytosis Assessment by Stage and Route of Administration
• Cutaneous Mastocytosis Assessment by Molecule Type
• Cutaneous Mastocytosis Assessment by Stage and Molecule Type
• Cutaneous Mastocytosis Therapeutics – Discontinued Products
• Cutaneous Mastocytosis Therapeutics – Dormant Products
• Products under Development by Companies, 2019


List of Figures
• Number of Products under Development for Cutaneous Mastocytosis, 2019
• Filed and Phase III Products, 2019
• Phase II Products, 2019
• Phase I and IND Filed Products, 2019
• Discovery and Pre-Clinical Stage Products, 2019
• Cutaneous Mastocytosis Assessment by Monotherapy Products
• Cutaneous Mastocytosis Assessment by Combination Products
• Cutaneous Mastocytosis Assessment by Route of Administration
• Cutaneous Mastocytosis Assessment by Stage and Route of Administration
• Cutaneous Mastocytosis Assessment by Molecule Type
• Cutaneous Mastocytosis Assessment by Stage and Molecule Type


*** レポートのキーワード ***

皮膚肥満細胞症(Cutaneous Mastocytosis)、治療薬、医薬品、薬剤、製薬企業、研究開発、治験、パイプライン

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • オンライン小売のトルコ市場
    Online Retail in Turkey Summary Online Retail in Turkey industry profile provides top-line qualitative and quantitative summary information including: market size (value 2014-18, and forecast to 2023). The profile also contains descriptions of the leading players including key financial metrics and …
  • 世界のポリブチレンテレフタレート(PBT)市場予測 2021年-2026年
    According to this latest study, the 2021 growth of Polybutylene Terephthalate (PBT) will have significant change from previous year. By the most conservative estimates of global Polybutylene Terephthalate (PBT) market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in …
  • 女性用衛生製品の世界市場2020年-2030年
    A recent market study published by Future Market Insights (FMI) on the feminine hygiene products market offers a global industry analysis for 2016-2020 & an opportunity assessment for 2021-2031. The report consists of a comprehensive assessment of the most important market dynamics. On conducting th …
  • 世界のLNG年鑑 2018年:液化天然ガスインフラの徹底ガイド
    The definitive LNG Yearbook 2018 is the ultimate reference source for the liquefied natural gas industry. The yearbook indicates that the global LNG infrastructure market including large and small-scale LNG, FLNG and Carriers will experience a total Capex of $55.6bn in 2018. The report will answer t …
  • チェコの調味料・ドレッシング・ソース市場:消費者およびマーケットインサイト
    Summary Economic recovery and rising purchasing power of consumers in the Czech republic will drive the demand for consumer packaged goods in the country. The Seasonings, Dressings and Sauces market is forecast to register higher growth during 2014-2019 compared to historic period. Wet Cooking Sauce …
  • 世界のバストランシーバ市場2019-2023
    The Bus Transceiver functions as a repeater for Bundled Cables and allows for power to be flowing in one direction but not the other. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. Bus Transceiver Report by Material, …
  • イギリスの電気生理学装置市場(~2021)
    United Kingdom Electrophysiology Devices Market Outlook to 2021 Summary GlobalData’s new report, United Kingdom Electrophysiology Devices Market Outlook to 2021, provides key market data on the United Kingdom Electrophysiology Devices market. The report provides value, in millions of US dollars, vol …
  • ピバレートの世界及び中国市場 2018年
    The 'Global and Chinese Pivalate Industry, 2013-2023 Market Research Report' is a professional and in-depth study on the current state of the global Pivalate industry with a focus on the Chinese market. The report provides key statistics on the market status of the Pivalate manufacturers and is a va …
  • タイのフェノール市場(~2019):市場規模、シェア、動向
    Phenol Industry Outlook in Thailand to 2019 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and Planned Plants Summary GlobalData’s new report, "Phenol Industry Outlook in Thailand to 2019 - Market Size, Company Share, Price Trends, Capacity Forecasts of All Active and P …
  • 世界及び中国のアルミ三フッ化ホウ素市場2017
    The 'Global and Chinese Aluminum Trifluoride Industry, 2012-2022 Market Research Report' is a professional and in-depth study on the current state of the global Aluminum Trifluoride industry with a focus on the Chinese market. The report provides key statistics on the market status of the Aluminum T …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DIPR2016159 )"皮膚肥満細胞症(Cutaneous Mastocytosis):治療薬開発パイプライン動向2019" (英文:Cutaneous Mastocytosis-Pipeline Insights, 2019)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。